ClinicalTrials.Veeva

Menu

the Value of Transanal Endoscopic ISR

S

Shanghai Minimally Invasive Surgery Center

Status

Completed

Conditions

Rectal Cancer

Treatments

Procedure: transanal endoscopic ISR

Study type

Observational

Funder types

Other

Identifiers

NCT05933785
taE-ISR

Details and patient eligibility

About

The Intersphincteric resection (ISR) technique is an alternative for anal preservation in ultra-low rectal cancer. The transanal total mesorectal excision (TaTME) technique might compensate for the deficiencies of ISR in terms of tumor spillage and poor surgical field exposure. Thus, the investigators perform ISR through a transanal endoscopic approach (taE-ISR), seeking to evaluate the value of this innovative technique in anal preservation in ultra-low rectal cancer.

Enrollment

260 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 75 years
  • American Society of Anesthesiologists (ASA) score I to III
  • A biopsy proven histological diagnosis of rectal carcinoma
  • preoperative stage as (y) cT1-3N0-2M0
  • lower margin of the tumor less than 5cm from the anus
  • tumor diameter ≤5cm

Exclusion criteria

  • Pregnant or lactating women
  • Synchronous rectal carcinoma
  • History of colorectal cancer or other malignant tumors
  • Clinical evidence of metastasis
  • Emergency procedure

Trial design

260 participants in 2 patient groups

transanal endoscopic ISR
Treatment:
Procedure: transanal endoscopic ISR
traditional ISR

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems